Revisor Wealth Management’s Medtronic MDT Stock Holding History

Revisor Wealth Management’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.06M	Buy	26,224 +4,134	+19%	+$333K	0.5%	46
2026 Q1	$1.92M	Buy	22,090 +151	+0.7%	+$14.5K	0.53%	41
2025 Q4	$2.17M	Buy	21,939 +9,044	+70%	+$878K	0.58%	39
2025 Q3	$1.25M	Sell	12,895 -537	-4%	-$49.4K	0.43%	49
2025 Q2	$1.2M	Buy	13,432 +8,361	+165%	+$709K	0.43%	45
2025 Q1	$459K	Buy	+5,071	New	+$454K	0.2%	121
2024 Q4	–	Sell	-2,748	Closed	-$247K	–	154
2024 Q3	$247K	Sell	2,748 -166	-6%	-$14K	0.15%	150
2024 Q2	$229K	Sell	2,914 -2,246	-44%	-$184K	0.16%	138
2024 Q1	$437K	Buy	5,160 +2,509	+95%	+$214K	0.2%	126
2023 Q4	$218K	Sell	2,651 -905	-25%	-$69K	0.25%	125
2023 Q3	$279K	Buy	3,556 +445	+14%	+$37.3K	0.24%	114
2023 Q2	$274K	Sell	3,111 -296	-9%	-$25.5K	0.25%	122
2023 Q1	$275K	Buy	+3,407	New	+$278K	0.25%	117

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Revisor Wealth Management's MDT Position: Q2 2026 in Review

Revisor Wealth Management increased its Medtronic (MDT) stake by 19% in Q2 2026, buying an estimated $333K and bringing the position to 26,224 shares worth $2.06M. The position accounts for 0.5% of the portfolio, ranked #46.

Revisor Wealth Management first reported a position in MDT in Q1 2023 and has held it in 13 quarters since. The position peaked at $2.17M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Revisor Wealth Management held 26,224 shares of Medtronic worth $2.06M as of Q2 2026.
Revisor Wealth Management bought 4,134 Medtronic shares in Q2 2026, an estimated $333K.
Medtronic made up 0.5% of Revisor Wealth Management's portfolio in Q2 2026, its #46 holding.
Revisor Wealth Management first reported a position in Medtronic in Q1 2023 and has held it in 13 quarters since.
Revisor Wealth Management's Medtronic position peaked at $2.17M in Q4 2025.
2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.